Search Results

There are 15632 results for: content related to: Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma

  1. Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

    European Journal of Haematology

    Volume 85, Issue 3, September 2010, Pages: 200–208, Francesca Gay, S. Vincent Rajkumar, Patrizia Falco, Shaji Kumar, Angela Dispenzieri, Maria Teresa Petrucci, Morie A. Gertz, Mario Boccadoro, A. Keith Stewart and Antonio Palumbo

    Version of Record online : 8 MAY 2010, DOI: 10.1111/j.1600-0609.2010.01469.x

  2. You have free access to this content
    Lenalidomide in multiple myeloma: current experimental and clinical data

    European Journal of Haematology

    Volume 88, Issue 4, April 2012, Pages: 279–291, Mauro Cives, Annalisa Milano, Franco Dammacco and Franco Silvestris

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1600-0609.2011.01735.x

  3. You have free access to this content
    Lenalidomide in multiple myeloma: Current status and future potential

    American Journal of Hematology

    Volume 87, Issue 12, December 2012, Pages: 1089–1095, Hang Quach, Anna Kalff and Andrew Spencer

    Version of Record online : 28 MAY 2012, DOI: 10.1002/ajh.23234

  4. You have free access to this content
    Oral Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 100–180,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2227

  5. You have free access to this content
    Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

    Cancer

    Volume 107, Issue 11, 1 December 2006, Pages: 2609–2616, Toni K. Choueiri, Robert Dreicer, Brian I. Rini, Paul Elson, Jorge A. Garcia, Snehal G. Thakkar, Rachid C. Baz, Tarek M. Mekhail, Holly A. Jinks and Ronald M. Bukowski

    Version of Record online : 30 OCT 2006, DOI: 10.1002/cncr.22290

  6. You have free access to this content
    Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone

    Cancer

    Volume 117, Issue 10, 15 May 2011, Pages: 2136–2144, Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt and Kai Neben

    Version of Record online : 4 DEC 2010, DOI: 10.1002/cncr.25775

  7. You have free access to this content
    Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents

    British Journal of Haematology

    Volume 156, Issue 5, March 2012, Pages: 619–625, David Sibon, Giovanna Cannas, Fiorenza Baracco, Thomas Prebet, Norbert Vey, Anne Banos, Caroline Besson, Selim Corm, Michel Blanc, Bohrane Slama, Hervé Perrier, Pierre Fenaux, Eric Wattel and on behalf of the Groupe Francophone des Myélodysplasies

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1365-2141.2011.08979.x

  8. You have free access to this content
    Flow cytometry-based enumeration and functional characterization of cd8 t regulatory cells in patients with multiple myeloma before and after lenalidomide plus dexamethasone treatment

    Cytometry Part B: Clinical Cytometry

    Volume 86, Issue 4, July 2014, Pages: 220–228, Karthick Raja Muthu Raja, Martin Plasil, Lucie Rihova, Jana Pelcova, Zdenek Adam and Roman Hajek

    Version of Record online : 6 AUG 2013, DOI: 10.1002/cyto.b.21109

  9. Pooled analysis of the reports of pomalidomide after failure of lenalidomide and (or) bortezomib for multiple myeloma

    Hematological Oncology

    Zhixin Sheng and Guangyu Liu

    Version of Record online : 3 FEB 2015, DOI: 10.1002/hon.2192

  10. You have free access to this content
    Multiple myeloma: chemotherapy or transplantation in the era of new drugs

    European Journal of Haematology

    Volume 84, Issue 5, May 2010, Pages: 379–390, Antonio Palumbo and S. Vincent Rajkumar

    Version of Record online : 23 MAR 2010, DOI: 10.1111/j.1600-0609.2010.01431.x

  11. You have full text access to this OnlineOpen article
    Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

    European Journal of Haematology

    Volume 93, Issue 5, November 2014, Pages: 429–438, Aristoteles Giagounidis, Ghulam J. Mufti, Moshe Mittelman, Guillermo Sanz, Uwe Platzbecker, Petra Muus, Dominik Selleslag, Odile Beyne-Rauzy, Peter te Boekhorst, Consuelo del Cañizo, Agnès Guerci-Bresler, Lars Nilsson, Michael Lübbert, Bruno Quesnel, Arnold Ganser, David Bowen, Brigitte Schlegelberger, Gudrun Göhring, Tommy Fu, Bouchra Benettaib, Eva Hellström-Lindberg and Pierre Fenaux

    Version of Record online : 9 JUN 2014, DOI: 10.1111/ejh.12380

  12. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  13. You have free access to this content
    Lenalidomide performance in the real world

    Cancer

    Volume 119, Issue 21, 1 November 2013, Pages: 3870–3878, Amer M. Zeidan, Steven D. Gore, Diane L. McNally, Maria R. Baer, Franklin Hendrick, Dalia Mahmoud and Amy J. Davidoff

    Version of Record online : 6 AUG 2013, DOI: 10.1002/cncr.28298

  14. Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital

    Asia-Pacific Journal of Clinical Oncology

    Volume 9, Issue 2, June 2013, Pages: 169–175, Marliese Alexander, Khai C Teoh, Senthil Lingaratnam, Sue Kirsa and James D Mellor

    Version of Record online : 24 SEP 2012, DOI: 10.1111/ajco.12013

  15. Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia

    Internal Medicine Journal

    Volume 41, Issue 3, March 2011, Pages: 286–288, N. Tageja, T. Giorgadze and J. Zonder

    Version of Record online : 22 MAR 2011, DOI: 10.1111/j.1445-5994.2011.02426.x

  16. You have free access to this content
    Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?

    British Journal of Haematology

    Volume 140, Issue 3, February 2008, Pages: 324–326, María-Victoria Mateos, Ramón García-Sanz, Enrique Colado, Juan Olazábal and Jesús San-Miguel

    Version of Record online : 7 DEC 2007, DOI: 10.1111/j.1365-2141.2007.06946.x

  17. You have free access to this content
    Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression

    British Journal of Haematology

    Volume 160, Issue 4, February 2013, Pages: 487–502, Ling-Hua Zhang, Jolanta Kosek, Maria Wang, Carla Heise, Peter H. Schafer and Rajesh Chopra

    Version of Record online : 18 DEC 2012, DOI: 10.1111/bjh.12172

  18. You have full text access to this OnlineOpen article
    Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN

    British Journal of Haematology

    Volume 164, Issue 6, March 2014, Pages: 811–821, Anita K. Gandhi, Jian Kang, Courtney G. Havens, Thomas Conklin, Yuhong Ning, Lei Wu, Takumi Ito, Hideki Ando, Michelle F. Waldman, Anjan Thakurta, Anke Klippel, Hiroshi Handa, Thomas O. Daniel, Peter H. Schafer and Rajesh Chopra

    Version of Record online : 13 DEC 2013, DOI: 10.1111/bjh.12708

  19. You have free access to this content
    Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1585–1592, Shaji K. Kumar, Martha Q. Lacy, Angela Dispenzieri, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Francesca Gay, Shirshendu Sinha, Nelson Leung, William Hogan, S. Vincent Rajkumar and Morie A. Gertz

    Version of Record online : 25 AUG 2011, DOI: 10.1002/cncr.26422

  20. You have free access to this content
    Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

    Clinical & Experimental Immunology

    Volume 175, Issue 1, January 2014, Pages: 49–58, A. C. Chan, P. Neeson, E. Leeansyah, K. Tainton, H. Quach, H. M. Prince, S. J. Harrison, D. I. Godfrey, D. Ritchie and S. P. Berzins

    Version of Record online : 3 DEC 2013, DOI: 10.1111/cei.12196